Christopher R. S. Banerji
Title
Cited by
Cited by
Year
Cellular network entropy as the energy potential in Waddington's differentiation landscape
CRS Banerji, D Miranda-Saavedra, S Severini, M Widschwendter, ...
Scientific Reports 3, 3039, 2013
982013
Increased signaling entropy in cancer requires the scale-free property of protein interaction networks
AE Teschendorff, CRS Banerji, S Severini, R Kuehn, P Sollich
Scientific reports 5, 9646, 2015
382015
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
CRS Banerji, M Panamarova, H Hebaishi, RB White, F Relaix, S Severini, ...
Nature Communications 8 (2152), 2017
362017
DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis
P Knopp, YD Krom, CRS Banerji, M Panamarova, LA Moyle, B den Hamer, ...
Journal of cell science 129 (20), 3816-3831, 2016
342016
Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer
CRS Banerji, S Severini, C Caldas, AE Teschendorff
PLoS Comput Biol 11 (3), e1004115, 2015
282015
β-catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy
CRS Banerji, P Knopp, LA Moyle, S Severini, RW Orrell, AE Teschendorff, ...
Journal of the Royal Society Interface 12 (102), 20140797, 2015
222015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
ML Lin, H Patel, J Remenyi, CRS Banerji, CF Lai, M Periyasamy, ...
Oncotarget, 2015
182015
Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy
CRS Banerji, M Panamarova, J Pruller, N Figeac, H Hebaishi, E Fidanis, ...
Human molecular genetics 28 (8), 1244-1259, 2019
152019
Network Transfer Entropy and Metric Space for Causality Inference
CRS Banerji, S Severini, AE Teschendorff
Phys. Rev. E 87, 052814, 2013
112013
PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level
CRS Banerji, PS Zammit
Human molecular genetics 28 (13), 2224-2236, 2019
92019
Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy
LA Moyle, E Blanc, O Jaka, J Prueller, CRS Banerji, FS Tedesco, ...
Elife 5, e11405, 2016
92016
A notion of graph likelihood and an infinite monkey theorem
CRS Banerji, T Mansour, S Severini
Journal of Physics A: Mathematical and Theoretical 47 (3), 035101, 2013
62013
DUX4-expressing immortalised FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation
CRS Banerji, MP Macura, PS Zammit
Human Molecular Genetics, 2020
3*2020
PAX7 target gene repression associates with FSHD progression and pathology over one year
CRS Banerji
Human Molecular Genetics, 2020
12020
Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms
CRS Banerji, P Cammish, T Evangelista, PS Zammit, V Straub, ...
Neuromuscular Disorders, 2020
12020
Skeletal muscle regeneration in Facioscapulohumeral muscular dystrophy is correlated with pathological severity
CRS Banerji, D Henderson, RN Tawil, PS Zammit
Human Molecular Genetics, 2020
2020
DEPDC1B is a key regulator of myoblast proliferation in mouse and man
N Figeac, J Pruller, I Hofer, M Fortier, HP Ortuste Quiroga, CRS Banerji, ...
Cell proliferation 53 (1), e12717, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–17